Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Exelixis Inc at Guggenheim Healthcare Talks Biotechnology Conference Transcript

Feb 08, 2024 / 02:00PM GMT
Release Date Price: $20.17 (-0.05%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

All right. Good morning, and welcome to the fireside chat with Exelixis. With us today, we have Mike Morrissey, CEO. Mike, welcome. Thanks for joining us.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Michael, good to see you. Great glasses.

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

Thank you. Appreciate it.

Questions & Answers

Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD

So yes, for those who don't know, I'm Michael Schmidt, biotech analysts with Guggenheim and we'll just jump right into Q&A, Mike. Perhaps starting just with a quick commercial question. You recently guided to 2024 revenue, [$1.65 billion to 1.75 billion] cabo sales for this year, which implies a slowdown from the prior year. Just remind folks again,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot